A Phase II Trial of LM103 for Adjuvant Treatment in Patients With Non-small Cell Lung Cancer
Clinical trial NCT07444437 · RECRUITING
Trial details
- NCT number
- NCT07444437
- Sponsor
- Suzhou BlueHorse Therapeutics Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-26
- Primary completion
- 2027-12-31
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.